Reporting mood changes and drug side effects to the FDA
The notice promotes reporting new or sudden mood or behavioral changes as potential drug side effects to the FDA. It encourages using MedWatch and provides the Wyeth Pharmaceuticals contact in Philadelphia for related information.
MENTIONED IN THIS ARTICLE
Duprestigh
Reece
U.S. Food and Drug Administration
Pristiq
Pristia
Pristig
St. John's
Pristig.com
FDA
Fda.gov
Medwatch
Pristiq.com
Wyeth.com
Medical Communications Department
Also Mentioned on This Page
Beret
Wyeth
Wyeth Pharmaceuticals Inc
Philadelphia
Wicssopol